{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:59:44Z","timestamp":1786993184988,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1919588"],"award-info":[{"award-number":["1919588"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005714","name":"Established Program to Stimulate Competitive Research","doi-asserted-by":"publisher","award":["-1655221"],"award-info":[{"award-number":["-1655221"]}],"id":[{"id":"10.13039\/100005714","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","award":["R24GM137786"],"award-info":[{"award-number":["R24GM137786"]}],"id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","award":["P30 GM122731"],"award-info":[{"award-number":["P30 GM122731"]}],"id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","award":["S10OD036343"],"award-info":[{"award-number":["S10OD036343"]}],"id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","award":["UL1TR002366"],"award-info":[{"award-number":["UL1TR002366"]}],"id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007859","name":"University of Kansas","doi-asserted-by":"publisher","award":["U54 HD090216"],"award-info":[{"award-number":["U54 HD090216"]}],"id":[{"id":"10.13039\/100007859","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK034989"],"award-info":[{"award-number":["P30DK034989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009680","name":"Yale Liver Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009680","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012848","name":"Digestive Diseases Research Core Center, University of Chicago","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014082","name":"University of Rhode Island Foundation & Alumni Engagement","doi-asserted-by":"publisher","award":["16425-139183"],"award-info":[{"award-number":["16425-139183"]}],"id":[{"id":"10.13039\/100014082","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103430"],"award-info":[{"award-number":["P20GM103430"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpba.2025.117244","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T09:07:13Z","timestamp":1762765633000},"page":"117244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6739-2699","authenticated-orcid":false,"given":"Amit","family":"Dahal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4647-8869","authenticated-orcid":false,"given":"Teresa","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Assis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Rostami-Hodjegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4724-0576","authenticated-orcid":false,"given":"Nisanne S.","family":"Ghonem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2595-5626","authenticated-orcid":false,"given":"Brahim","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117244_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/17512433.2018.1501271","article-title":"Precision dosing in clinical medicine: present and future","volume":"11","author":"Polasek","year":"2018","journal-title":"Expert Rev. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117244_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-pharmtox-033020-113257","article-title":"Model-informed precision dosing: background, requirements, validation, implementation, and forward trajectory of individualizing drug therapy","volume":"61","author":"Darwich","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2025.117244_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.clpt.6100406","article-title":"The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype","volume":"83","author":"Gaedigk","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/clpt.2014.83","article-title":"Geneva cocktail for cytochrome P450 and P-glycoprotein activity assessment using dried blood spots","volume":"96","author":"Bosilkovska","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2125.2010.03773.x","article-title":"4\u03b2-Hydroxycholesterol, an endogenous marker of CYP3A4\/5 activity in humans","volume":"71","author":"Diczfalusy","year":"2011","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117244_bib6","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/1389200218666170724110818","article-title":"Endogenous biomarkers to assess drug-drug interactions by drug transporters and enzymes","volume":"18","author":"Mariappan","year":"2017","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2025.117244_bib7","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/dmd.122.001066","article-title":"Novel approaches to characterize individual drug metabolism and advance precision medicine","volume":"51","author":"Jackson","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2025.117244_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140712","article-title":"Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA","volume":"10","author":"Lanman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.117244_bib9","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cpt.2576","article-title":"Liquid biopsy for patient characterization in cardiovascular disease: verification against markers of cytochrome P450 and P-glycoprotein activities","volume":"111","author":"Achour","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcp.13793","article-title":"Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure","volume":"85","author":"Rowland","year":"2019","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117244_bib11","first-page":"137","article-title":"On the verge of impossibility: Accounting for variability arising from permutations of comorbidities that affect the fate of drugs in the human body","volume":"9","author":"Rostami-Hodjegan","year":"2023"},{"key":"10.1016\/j.jpba.2025.117244_bib12","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cpt.2102","article-title":"Liquid biopsy enables quantification of the abundance and interindividual variability of hepatic enzymes and transporters","volume":"109","author":"Achour","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cpt.3291","article-title":"Dealing with variable drug exposure due to variable hepatic metabolism: a proof-of-concept application of liquid biopsy in renal impairment","volume":"116","author":"Rostami-Hodjegan","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/cpt.2633","article-title":"Quantitative proteomics of hepatic drug-metabolizing enzymes and transporters in patients with colorectal cancer metastasis","volume":"112","author":"Vasilogianni","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jprot.2014.07.012","article-title":"Multi-enzyme digestion FASP and the \u2018Total Protein Approach\u2019-based absolute quantification of the Escherichia coli proteome","volume":"109","author":"Wi\u015bniewski","year":"2014","journal-title":"J. Proteom."},{"key":"10.1016\/j.jpba.2025.117244_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2022.104601","article-title":"Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease","volume":"263","author":"Vasilogianni","year":"2022","journal-title":"J. Proteom."},{"key":"10.1016\/j.jpba.2025.117244_bib17","article-title":"FastQC: a quality control tool for high throughput sequence data","author":"Andrews","year":"2010","journal-title":"Babraham Bioinforma."},{"key":"10.1016\/j.jpba.2025.117244_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpba.2025.117244_bib19","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpba.2025.117244_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.jpba.2025.117244_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jpba.2025.117244_bib22","doi-asserted-by":"crossref","first-page":"W566","DOI":"10.1093\/nar\/gkv468","article-title":"ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap","volume":"43","author":"Metsalu","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpba.2025.117244_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jpba.2025.117244_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jgh3.12223","article-title":"Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population","volume":"4","author":"Alomari","year":"2019","journal-title":"JGH Open"},{"key":"10.1016\/j.jpba.2025.117244_bib25","unstructured":"A. Rostami-Hodjegan, B. Achour, J.E. Rothman, 2021. Methods and apparatus for quantifying protein abundance in tissues via cell free ribonucleic acids in liquid biopsy. Patent number WO2019191297."},{"key":"10.1016\/j.jpba.2025.117244_bib26","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1365-2036.2006.03155.x","article-title":"Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis","volume":"24","author":"Rautiainen","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1365-2125.1984.tb02517.x","article-title":"Pharmacokinetic study of cyclosporin A (Sandimmun) in patients with primary biliary cirrhosis","volume":"18","author":"Robson","year":"1984","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117244_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.1992.tb00559.x","article-title":"Oral pharmacokinetics of cyclosporin in patients with primary biliary cirrhosis and patients with skin diseases","volume":"6","author":"Beukers","year":"1992","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib29","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/pharmaceutics15092237","article-title":"Understanding discordance between in vitro dissolution, local gut and systemic bioequivalence of budesonide in healthy and Crohn's disease patients through PBPK modeling","volume":"15","author":"Han","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jpba.2025.117244_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cpt.3529","article-title":"Inhibition of OATP1B1\/3 rather than UGT1A1 may be the major cause of the bilirubin elevation after atazanavir administration","volume":"118","author":"Dong","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib31","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1124\/dmd.107.017806","article-title":"Characterization of the UDP glucuronosyltransferase activity of human liver microsomes genotyped for the UGT1A1*28 polymorphism","volume":"35","author":"Zhang","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2025.117244_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.37349\/edd.2023.00024","article-title":"Pathophysiology of biochemical signs of primary biliary cholangitis","volume":"2","author":"Reshetnyak","year":"2023","journal-title":"Explor. Dig. Dis."},{"key":"10.1016\/j.jpba.2025.117244_bib33","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1172\/JCI106184","article-title":"Studies of bilirubin kinetics in normal adults","volume":"48","author":"Berk","year":"1969","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jpba.2025.117244_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.1840400412","article-title":"Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer","volume":"40","author":"Zucker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jpba.2025.117244_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.jpba.2025.117244_bib36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cpt.1930","article-title":"Fenofibrate improves liver function and reduces the toxicity of the bile acid pool in patients with primary biliary cholangitis and primary sclerosing cholangitis who are partial responders to ursodiol","volume":"108","author":"Ghonem","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib37","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.3748\/wjg.v29.i34.5075","article-title":"Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis","volume":"29","author":"Zhu","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jpba.2025.117244_bib38","unstructured":"US Food and Drug Administration, Enhancing the diversity of clinical trial populations\u2014eligibility criteria, enrollment practices, and trial designs - guidance for industry. \u3008https:\/\/www.fda.gov\/science-research\/clinical-trials-and-human-subject-protection\/clinical-trials-guidance-documents\u3009, 2020 (accessed 07 July 2025)."},{"key":"10.1016\/j.jpba.2025.117244_bib39","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cpt.2056","article-title":"Proteomics-informed prediction of rosuvastatin plasma profiles in patients with a wide range of body weight","volume":"109","author":"Wegler","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116153","article-title":"Rapid isolation of extracellular vesicles using covalent organic frameworks combined with microfluidic technique","volume":"245","author":"Xin","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117244_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117211","article-title":"Plasma extracellular vesicle proteomics identifies FN1\/F13A1\u2013TGF-\u03b2 pathway as the major signaling pathway associated with persistent atrial fibrillation","volume":"268","author":"Zhang","year":"2026","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117244_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106375","article-title":"Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling","volume":"182","author":"Barber","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117244_bib43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/cpt.1778","article-title":"Virtual twins: understanding the data required for model-informed precision dosing","volume":"107","author":"Polasek","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.117244_bib44","first-page":"5252","article-title":"Down-regulation of OATP1B proteins correlates with hyperbilirubinemia in advanced cholestasis","volume":"8","author":"Sticova","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.jpba.2025.117244_bib45","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1386-6346(01)00159-0","article-title":"Expression of the hepatocyte canalicular multidrug resistance protein (MRP2) in primary biliary cirrhosis","volume":"23","author":"Kullak-Ublick","year":"2002","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jpba.2025.117244_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1034\/j.1600-0676.2001.021004247.x","article-title":"Expression of hepatic transporters OATP-C and MRP2 in primary sclerosing cholangitis","volume":"21","author":"Oswald","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.jpba.2025.117244_bib47","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","article-title":"Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis","volume":"38","author":"Zollner","year":"2003","journal-title":"J. Hepatol."}],"updated-by":[{"DOI":"10.1016\/j.jpba.2026.117385","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000}}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:13:37Z","timestamp":1781122417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0731708525005850"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117244","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: Proof-of-concept application to cholestatic liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117244"}}